Condition: Fuchs' Endothelial Dystrophy · Fuchs Dystrophy · Fuchs · Sponsor: Trefoil Therapeutics, Inc.
Open label, single-treatment, with a concurrent non-treatment control
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Trefoil Investigational Site 124 | Long Beach, California, United States | — |
| North Bay Eye Associates | Petaluma, California, United States | — |
| Trefoil Investigational Site 123 | Deerfield Beach, Florida, United States | — |
| Trefoil Investigational Site 119 | Fort Myers, Florida, United States | — |
| Price Vision Group | Indianapolis, Indiana, United States | — |
| Tauber Eye Center | Kansas City, Missouri, United States | — |
| Vance Thompson Vision - Bozeman | Bozeman, Montana, United States | — |
| Vance Thompson Vision - Omaha | Omaha, Nebraska, United States | — |
| Vance Thompson Vision - Fargo | West Fargo, North Dakota, United States | — |
| Trefoil Investigational Site 120 | Cincinnati, Ohio, United States | — |
| Vance Thompson Vision - Sioux Falls | Sioux Falls, South Dakota, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04676737